23.06.2019, 2936 Zeichen

Valneva: Valneva SE, a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, today announces that GSK and Valneva have decided, by mutual agreement, to end the Strategic Alliance Agreement, originally agreed between Novartis and Intercell (predecessor companies of GSK and Valneva, respectively). Valneva will pay Euro 9 mn to GSK immediately and up to a further Euro 7 mn in milestones relating to marketing approvals of its Lyme vaccine. As a result, Valneva is now fully in control of its main R&D assets including its Lyme vaccine candidate VLA15.  Valneva-CEO Thomas Lingelbach: “We would like to thank GSK and, previously, Novartis, for the legacy partnership. I am delighted that Valneva is now solely able to determine its entire development strategy for all vaccine candidates, including Lyme and chikungunya whilst being in the position to capture their entire economic potential. I am confident that we can fully address these very serious threats to public health whilst simultaneouslymaximising value for our shareholders.”
Valneva: weekly performance: -1.50%

Lenzing: Austrian based fibers producer Lenzing Group will drastically reduce its CO2 footprint. The Lenzing Group will invest Euro 100 mn over the coming years to reduce carbon emissions both inside its operational boundaries (scope 1+2) and in its supply chain (scope 3). A first milestone is set for 2030, when Lenzing plans to reduce CO2 emissions per ton of product by almost 50% (scope 1+2 and 3) compared to a 2017 baseline. The total CO2 reduction of all the planned initiatives will yield 1.3 mn tons (Mt). “Climate change is the most important issue mankind is facing. With this commitment we are fully in line with the Paris climate agreement and will further help the world to reduce the speed of global warming. Our ambitious decarbonization targets make us a front runner, not only in the world of fiber producers but also among major industrial companies. Despite the substantial investment that is necessary, we are convinced that this is not only a very responsible step but that it will also be a value-generating move”, says CEO Stefan Doboczky.
Lenzing: weekly performance: -3.18%

Frequentis: The over-allotment (greenshoe) granted by Frequentis AG at its IPO in Vienna and Frankfurt from the portfolio of the majority shareholder and Chairman of the Supervisory Board Johannes Bardach was used to some 58%. A total of 2,873,975 shares (of which 173,975 shares from the over-allotment / greenshoe) were placed on the capital market at a price of Euro 18.00. The total placement volume amounted to Euro 51.7 mn, of which Euro 21.6 mn went directly to Frequentis as gross proceeds. The total number of shares after the IPO is unchanged at 13.2 mn shares, the company announced.
Frequentis: weekly performance: -0.11%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (21/06/2019)

Christian Drastil: Wiener Börse Plausch

SportWoche Podcast #140: Flag Football und Österreichs Top-Position dabei, erklärt von Ines-Jeanne Paupie

Bildnachweis

Aktien auf dem Radar:Pierer Mobility, UBM, Palfinger, Immofinanz, Addiko Bank, CA Immo, SBO, Porr, Rosenbauer, EuroTeleSites AG, Frequentis, Kostad, Linz Textil Holding, Marinomed Biotech, Wiener Privatbank, Warimpex, Agrana, Amag, EVN, Flughafen Wien, OMV, Österreichische Post, Telekom Austria, Uniqa, VIG, E.ON , BASF, Zalando, Mercedes-Benz Group, Allianz, Hannover Rück.

---